STOCK TITAN

Xylo Technologies Announces Plan to Implement ADS Ratio Change

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

Xylo Technologies (Nasdaq: XYLO) has announced a planned reverse split of its American Depositary Receipt (ADR) program. The ratio change will be 1 new ADS for every 2.666666 old ADSs. Each new ADS will represent 40 ordinary shares, up from the previous 15. The effective date is set for August 5, 2024. Xylo's ADSs will continue trading on Nasdaq under the symbol 'XYLO' with a new CUSIP Number. ADS holders must surrender their old ADSs to BNY Mellon for cancellation. The change will not affect the company's ordinary shares or alter shareholders' ownership percentages, except for minor adjustments due to fractional ADSs.

Xylo Technologies (Nasdaq: XYLO) ha annunciato un piano di riduzione del capitale per il suo programma di American Depositary Receipt (ADR). Il nuovo rapporto sarà 1 nuovo ADS per ogni 2,666666 vecchi ADS. Ogni nuovo ADS rappresenterà 40 azioni ordinarie, rispetto alle precedenti 15. La data di efficacia è fissata per il 5 agosto 2024. Gli ADS di Xylo continueranno a essere scambiati su Nasdaq sotto il simbolo 'XYLO' con un nuovo numero CUSIP. I detentori di ADS devono restituire i loro vecchi ADS a BNY Mellon per la cancellazione. La modifica non influirà sulle azioni ordinarie della società né altererà le percentuali di proprietà degli azionisti, tranne per lievi aggiustamenti dovuti a frazioni di ADS.

Xylo Technologies (Nasdaq: XYLO) ha anunciado un plan de división inversa para su programa de American Depositary Receipt (ADR). El nuevo ratio será de 1 nuevo ADS por cada 2.666666 ADS viejos. Cada nuevo ADS representará 40 acciones ordinarias, en comparación con las 15 anteriores. La fecha de efectividad se establece para el 5 de agosto de 2024. Los ADS de Xylo continuarán cotizando en Nasdaq bajo el símbolo 'XYLO' con un nuevo número CUSIP. Los titulares de ADS deben entregar sus ADS viejos a BNY Mellon para su cancelación. El cambio no afectará las acciones ordinarias de la compañía ni alterará los porcentajes de propiedad de los accionistas, excepto por ajustes menores debido a ADS fraccionarios.

Xylo Technologies (Nasdaq: XYLO)는 미국 예탁증서(ADR) 프로그램의 역분할을 계획하고 있다고 발표했습니다. 비율 변경은 새로운 ADS 1주당 2.666666개의 구형 ADS이 될 것입니다. 각 새로운 ADS는 40개의 보통주를 나타내며, 이는 이전의 15주에서 증가한 수치입니다. 시행일자는 2024년 8월 5일로 설정되었습니다. Xylo의 ADS는 새로운 CUSIP 번호로 'XYLO'라는 기호로 Nasdaq에서 계속 거래됩니다. ADS 보유자는 구형 ADS를 BNY Mellon에 반납하여 취소해야 합니다. 이 변경은 회사의 보통주에 영향을 미치지 않으며 주주들의 소유 비율을 변경하지 않지만, 소수점 이하의 ADS로 인한 경미한 조정이 있을 수 있습니다.

Xylo Technologies (Nasdaq: XYLO) a annoncé une division inversée de son programme d'American Depositary Receipt (ADR). Le nouveau ratio sera de 1 nouvel ADS pour chaque 2,666666 anciens ADS. Chaque nouvel ADS représentera 40 actions ordinaires, contre 15 précédemment. La date d'entrée en vigueur est fixée au 5 août 2024. Les ADS de Xylo continueront à être négociés sur le Nasdaq sous le symbole 'XYLO' avec un nouveau numéro CUSIP. Les détenteurs d'ADS doivent remettre leurs anciens ADS à BNY Mellon pour annulation. Ce changement n'affectera pas les actions ordinaires de l'entreprise ni ne modifiera les pourcentages de propriété des actionnaires, sauf pour des ajustements mineurs dus à des ADS fractionnaires.

Xylo Technologies (Nasdaq: XYLO) hat eine geplante Umkehraktienaufteilung für sein American Depositary Receipt (ADR) Programm angekündigt. Das neue Verhältnis wird 1 neuer ADS für jeden 2,666666 alten ADS betragen. Jeder neue ADS wird 40 Stammaktien darstellen, im Vergleich zu den vorherigen 15. Das Datum des Inkrafttretens ist auf den 5. August 2024 festgelegt. Die ADS von Xylo werden weiterhin unter dem Symbol 'XYLO' an der Nasdaq gehandelt, mit einer neuen CUSIP-Nummer. ADS-Inhaber müssen ihre alten ADS an BNY Mellon zur Stornierung abgeben. Die Änderung wird keine Auswirkungen auf die gewöhnlichen Aktien des Unternehmens haben und die Eigentumsanteile der Aktionäre nicht verändern, abgesehen von geringfügigen Anpassungen aufgrund von fractional ADS.

Positive
  • Continued listing on Nasdaq Capital Market
  • Uniform treatment of all ADS holders
  • No reduction in shareholders' ownership percentage (except for fractional adjustments)
Negative
  • Mandatory surrender of old ADSs required
  • Potential cash distribution for fractional ADSs instead of shares

Xylo Technologies' announcement of an ADS ratio change is a significant development that warrants attention from investors. This reverse split, changing from 15 to 40 ordinary shares per ADS, is likely aimed at boosting the ADS price and maintaining Nasdaq listing compliance.

Key points to consider:

  • Price Impact: The 2.666666-to-1 reverse split will theoretically increase the ADS price by the same factor, potentially making it more attractive to institutional investors and reducing the risk of delisting.
  • Share Count: While the total number of ADSs will decrease, individual investors' ownership percentages should remain largely unchanged, barring minor adjustments from fractional shares.
  • Market Perception: Reverse splits can sometimes be viewed negatively as they're often associated with struggling companies. However, if Xylo can demonstrate strong fundamentals, this move could be seen as a strategic step towards attracting more institutional investors.
  • Liquidity: There might be a short-term decrease in liquidity as the number of tradable ADSs reduces. Investors should monitor trading volumes post-split.

While this move doesn't directly affect Xylo's underlying business or financials, it's important for investors to understand the company's motives and potential market reactions. The success of this strategy will largely depend on Xylo's ability to leverage this change for improved market positioning and investor relations.

Xylo Technologies' ADS ratio change is a strategic move that could have several implications for the company's market positioning and investor base. Let's break down the potential impacts:

  • Investor Profile Shift: The higher post-split ADS price might attract more institutional investors, who often have minimum price thresholds for investments. This could lead to a more stable, long-term oriented shareholder base.
  • Index Inclusion Prospects: A higher ADS price could improve Xylo's chances of inclusion in certain stock indices, potentially increasing demand for the stock and improving liquidity.
  • Perception Management: While reverse splits can sometimes be viewed negatively, Xylo's diverse portfolio spanning medical solutions, internet technologies and EV charging could help mitigate concerns. The company needs to effectively communicate its growth strategy alongside this financial maneuver.
  • Competitive Positioning: In the tech sector, stock price can sometimes be seen as a proxy for company health. A higher ADS price could potentially enhance Xylo's perceived standing among peers, particularly in the competitive EV and medical technology spaces.

Investors should closely monitor Xylo's communications and performance metrics in the months following the ratio change. The company's ability to capitalize on this move through improved investor relations, potential new partnerships, or enhanced market visibility will be important in determining the long-term success of this strategy.

Tel Aviv, Israel, July 30, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” and the “Company”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that it plans a ratio change which will result in a reverse split of the Company’s American Depositary Receipt, or ADR, program on the basis of one (1) new ADS for every 2.666666 old ADSs held. As a result, the number of ordinary shares of the Company represented by each American Depositary Share, or ADS, will be changed from fifteen (15) ordinary shares to forty (40) ordinary shares. The effective date anticipated for the reverse split and the ratio change is August 5, 2024 and the Company’s ADSs will continue to be traded on the Nasdaq Capital Market under the symbol “XYLO” with a new CUSIP Number 58471G 508. The ordinary shares of Xylo will not be affected by this change in the ADS to ordinary share ratio.

Effective August 5, 2024, ADS holders will be required on a mandatory basis to surrender their old ADSs to BNY Mellon for cancellation at a rate of one (1) new ADS for every 2.666666 old ADS held. The Bank of New York Mellon., as the depositary bank for Xylo’s ADS program, will arrange for the exchange of current ADSs for new ADSs (subject to receipt of applicable ADS fees from the exchanging ADS holders).

Only whole ADSs will be distributed. BNY Mellon will attempt to sell any fractional ADSs and distribute cash proceeds to ADR holders. The ratio change will affect all ADS holders uniformly, will not reduce any ADS holder’s ownership percentage in the Company except for minor adjustments that may result from the treatment of fractional ADSs and will not result in any change to the Company’s share capital.

About Xylo

Based in Israel, Xylo Technologies Ltd. (Nasdaq: XYLO) is a technologies company that is focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce, and electric vehicle markets. Xylo’ affiliations in the medical solutions arena include the ownership in Polyrizon Ltd. The Company’s affiliates in digital commerce include Gix Internet Ltd., and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics, Inc. and Revoltz Ltd. are also part of the Company’s portfolio of technology solution providers. Other affiliations of the Company include Parazero Technologies Ltd., Zig Miami 54 LLC.

Xylo is traded on The Nasdaq Capital Market. To learn more about Xylo’s advanced technologies, please visit http://www.medigus.com/investor-relations.
  

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Xylo’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Xylo could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Xylo undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Xylo is not responsible for the contents of third-party websites.

Company Contact:

Tali Dinar
Chief Financial Officer
ir@xylotech.ai

Investor Relations Contact:
Michal Efraty
Investor Relations
michal@efraty.com 


FAQ

What is the new ADS to ordinary share ratio for Xylo Technologies (XYLO)?

The new ratio will be 1 ADS representing 40 ordinary shares of Xylo Technologies, effective August 5, 2024.

When will the Xylo Technologies (XYLO) ADS reverse split take effect?

The reverse split for Xylo Technologies' ADSs is scheduled to take effect on August 5, 2024.

Will Xylo Technologies (XYLO) change its Nasdaq trading symbol after the ADS ratio change?

No, Xylo Technologies will continue to trade on the Nasdaq Capital Market under the symbol 'XYLO' after the ADS ratio change.

How will fractional ADSs be handled in Xylo Technologies' (XYLO) reverse split?

BNY Mellon will attempt to sell any fractional ADSs resulting from the reverse split and distribute cash proceeds to ADS holders.

Medigus Ltd. American Depositary Share

NASDAQ:MDGS

MDGS Rankings

MDGS Latest News

MDGS Stock Data

4.47M
28.42M
0.29%
0.22%
Medical Devices
Healthcare
Link
United States of America
Tel Aviv